Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal chemistry and chemical biology with the department of pharmacology and the Barshop Institute at The University of Texas Health Science […]
Share This Story
This story is featured in the April 2025 Bexar County Medical Society’s San Antonio Medicine magazine About one in 10 Texans is living with Type 2 diabetes — one of the highest rates of the disease in the United States. In San Antonio, the rate is one in six people and another third of the […]
Share This Story
BRCA1 and BRCA2 are genes that help protect the body by fixing damaged DNA and keeping cells healthy. When these genes have changes, or mutations, they don’t work the way they should. This can raise the risk of certain cancers, like breast, ovarian, prostate and pancreatic cancer. These inherited mutations affect about 1 in every 200 to 300 people — over a million in the U.S. alone.
Share This Story
An ancient movement technique is merging with cutting-edge technology in a novel study at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) aimed at preventing falls in people with Alzheimer’s disease and related dementias. Wei Liu, PhD, research director of the Human Performance and Rehabilitation Research Lab and associate […]
Share This Story
Maria E. Falzone, PhD, assistant professor in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has received a $150,000 UT Science and Technology Acquisition and Retention (STARs) award from the […]
Share This Story
Researchers at The University of Texas Health Science Center at San Antonio have discovered a way to delay or even block recurrence of the deadliest brain cancer after radiation, bringing new hope for survival.
Share This Story
New hope for adult sufferers of most common primary brain tumor A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults. Results of a trial led by the university revealed that […]
Share This Story
The American Society for Gastrointestinal Endoscopy (ASGE) recently announced that Prabhleen Chahal, MD, FASGE, FACG, the Steven Schenker Distinguished Professor in Medicine (Tenure) and chief of the Division of Gastroenterology and Human Nutrition in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio […]
Share This Story
Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse with many different drivers. A longtime goal for scientists in this field is finding a single drug that […]
Share This Story
Content provided by Claire Kowalick A study published in the International Wound Journal conducted by researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) revealed risk factors for reinfection after treatment of a diabetic foot infection. The study found nearly half of patients who receive treatment for diabetic foot infections will experience […]
Share This Story